CREATIC at the CERTAINTY Annual Meeting 2025 in Paris
Regina Demlova and Jakub Jamárik represented CREATIC at the CERTAINTY Annual Meeting 2025 in Paris. Over two intensive days at Institut Curie, leading researchers, clinicians and project partners came together to share progress across the consortium, align on next steps within the work packages, and discuss long term sustainability of the initiative.
The meeting provided an important platform to exchange insights and ensure that scientific, clinical and operational activities remain closely connected. Alongside project updates, discussions focused on strengthening collaboration across disciplines and countries, supporting smooth implementation of ongoing tasks, and building a shared vision that will shape the future direction and impact of CERTAINTY.
A key highlight was the opportunity to hear directly from patients. Their experiences and perspectives are at the heart of the project and a powerful reminder of why innovation and partnership in this field matter. Listening to patients reinforces our responsibility to translate research into solutions that are meaningful in real life, and to keep outcomes oriented toward those who need them most.
CREATIC is proud to contribute to CERTAINTY and to be part of a community working to advance healthcare solutions for multiple myeloma. Meetings like this one are essential for maintaining momentum, strengthening coordination, and ensuring that the consortium continues to deliver results with clear relevance for patients, clinicians and healthcare systems.
